Skip to main content
. 2015 Nov 27;89(6):295–299. doi: 10.4174/astr.2015.89.6.295

Table 2. Treatment modalities for MALT lymphoma patients.

graphic file with name astr-89-295-i002.jpg

MALT, mucosa-associated lymphoid tissue; R-CVP, rituximab with cyclophosphamide, vincristine, and prednisone; RT, radiotherapy; R-CHOP, rituximab with cyclophosphamide, doxorubicin, cyclophosphamide and prednisone; CVP, cyclophosphamide, vincristine, and prednisone.